205 related articles for article (PubMed ID: 23544055)
1. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
[TBL] [Abstract][Full Text] [Related]
3. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S
Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799
[TBL] [Abstract][Full Text] [Related]
4. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
5. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
[TBL] [Abstract][Full Text] [Related]
6. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
[TBL] [Abstract][Full Text] [Related]
8. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
9. SOX2 Gene Amplification and Overexpression is Linked to HPV-positive Vulvar Carcinomas.
Gut A; Moch H; Choschzick M
Int J Gynecol Pathol; 2018 Jan; 37(1):68-73. PubMed ID: 28700423
[TBL] [Abstract][Full Text] [Related]
10. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
11. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E
Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372
[TBL] [Abstract][Full Text] [Related]
12. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
13. SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.
González-Márquez R; Llorente JL; Rodrigo JP; García-Pedrero JM; Álvarez-Marcos C; Suárez C; Hermsen MA
Hum Pathol; 2014 Apr; 45(4):851-7. PubMed ID: 24656096
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
15. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns.
Franchi A; Moroni M; Massi D; Paglierani M; Santucci M
Am J Surg Pathol; 2002 Dec; 26(12):1597-604. PubMed ID: 12459626
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation.
Tsou YA; Huang HJ; Wang TC; Tai CJ; Chen CM; Chen CY
Biomed Res Int; 2014; 2014():634945. PubMed ID: 25013792
[TBL] [Abstract][Full Text] [Related]
17. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
[TBL] [Abstract][Full Text] [Related]
18. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
[TBL] [Abstract][Full Text] [Related]
19. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
Fang W; French CA; Cameron MJ; Han YD; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
[TBL] [Abstract][Full Text] [Related]
20. SOX2 expression and prognostic significance in ovarian carcinoma.
Pham DL; Scheble V; Bareiss P; Fischer A; Beschorner C; Adam A; Bachmann C; Neubauer H; Boesmueller H; Kanz L; Wallwiener D; Fend F; Lengerke C; Perner S; Fehm T; Staebler A
Int J Gynecol Pathol; 2013 Jul; 32(4):358-67. PubMed ID: 23722508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
